issue

Dec 6, 2019

Volume 15 Number 11

In this issue the NOTION TRIAL looks at the cost-effectiveness of TAVI in patients at lower surgical risk; the final results of the REDUCE trial examining the optimal duration of DAPT in ACS patients treated with DES; a look at the impact of FFR in guiding CABG – the GRAFFITI trial; BIOFLOW-IV, studying the Orsiro sirolimus-eluting stent; and a study of multivessel PCIs in patients with acute myocardial infarction (AMI) and severe renal dysfunction.

Editorial

Antiplatelet strategies for complex PCI
Capodanno D
10.4244/EIJV15I11A174
free
Short DAPT duration after ACS – not for the faint of heart
Mihatov N, Yeh R
10.4244/EIJV15I11A175
free
Are all DES equal at 10-year follow-up?
Bär S, Windecker S, Räber L
10.4244/EIJV15I11A176
free
FFR for CABG: not ready for prime time
Gaudino M, Di Franco A, Taggart D
10.4244/EIJV15I11A177
free
Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?
Galper B, Baron S, Cohen D
10.4244/EIJV15I11A179
free

Perspectives

Interventions for valvular disease and heart failure

The changing landscape of aortic valve replacement in the USA
Gupta T, Kolte D, Khera S, Goel K, Villablanca P, Kalra A, Abbott J, Elmariah S, Fonarow G, Rihal C, Garcia M, Weisz G, Bhatt D
10.4244/EIJ-D-19-00381
free
Preclinical evaluation of a transcatheter aortic valve replacement system for patients with rheumatic heart disease
Scherman J, Ofoegbu C, Myburgh A, Swanevelder J, van Breda B, Appa H, Human P, Williams D, Bezuidenhout D, Zilla P
10.4244/EIJ-D-18-01052
free
Transcatheter mitral valve replacement: factors associated with screening success and failure
Coisne A, Pontana F, Tchétché D, Richardson M, Longère B, Vahdat O, Berthoumieu P, Van Belle E, Rousse N, Lancellotti P, Montaigne D, Dumonteil N, Modine T
10.4244/EIJ-D-19-00444
free

Coronary interventions

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)
De Luca G, Damen S, Camaro C, Benit E, Verdoia M, Rasoul S, Liew H, Polad J, Ahmad W, Zambahari R, Postma S, Kedhi E, Suryapranata H
10.4244/EIJ-D-19-00539
free
Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial
Toth GG, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piróth Z, Fournier S, Piccoli A, van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E
10.4244/EIJ-D-19-00463
free
Multivessel percutaneous coronary intervention in patients with acute myocardial infarction and severe renal dysfunction
Song P, Hahn J, Gwon H, Jeon K, Yu C, Rha S, Yoon C, Jeong MH
10.4244/EIJ-D-19-00034
free
Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study
Pareek M, Madsen M, Warnakula Olesen K, Jensen L, Christiansen E, Kristensen SD, Lassen JF, Thuesen L, Bøtker H, Maeng M
10.4244/EIJ-D-19-00503
free
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention
Azzalini L, Bellini B, Montorfano M, Carlino M
10.4244/EIJ-D-19-00175
free
Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved